30 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GRFS Grifols, S.A. $20.42 $13.96B N/A
Article Searches
GRFS vs. IONS: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/760441/grfs-vs-ions-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-760441 Feb 11, 2020 - GRFS vs. IONS: Which Stock Is the Better Value Option?
GRFS or ORINY: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/411754/grfs-or-oriny-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-411754 May 09, 2019 - GRFS vs. ORINY: Which Stock Is the Better Value Option?
Is Grifols, S.A. (GRFS) a Great Stock for Value Investors? http://www.zacks.com/stock/news/323331/is-grifols-sa-grfs-a-great-stock-for-value-investors?cid=CS-ZC-FT-323331 Sep 17, 2018 - Is Grifols, S.A. (GRFS) a great pick from the value investor's perspective right now? Read on to know more.
GRFS: Barclays starts at Overweight http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180601083059 Jun 01, 2018 - Barclays issues rating change for GRFS
Henry Schien to Distribute Grifols Product in United States http://www.zacks.com/stock/news/294616/henry-schien-to-distribute-grifols-product-in-united-states?cid=CS-ZC-FT-294616 Mar 06, 2018 - We expect Henry Schien's (HSIC) partnership with Grifols to be strategically accretive to its portfolio given the rising demand for saline products in U.S. market.
GRF eliminates two-tiered golf fee proposal, passes ‘members first’ resolution http://www.ocregister.com/2017/11/07/grf-eliminates-two-tiered-golf-fee-proposal-passes-members-first-resolution/ Nov 07, 2017 - Golf fees for all residents will increase, passed unanimously by the Golden Rain Foundation board on Tuesday, Nov.7. The board agreed to eliminate the two-tiered golf fees for members and nonmembers proposed at its October meeting. The resolution states the new golf fees for the 27-hole course for 18 holes will increase from $11 to […]
Meet the candidates for GRF board http://www.ocregister.com/2017/10/10/meet-the-candidates-for-grf-board/ Oct 10, 2017 - Golden Rain Foundation has named the five candidates to contend for four vacancies on the GRF board. They are JoAnn diLorenzo, Kathryn Freshley, James Juhan, James Matson and Annette Sabol Soule. Expiring are the terms of John Beckett, JoAnn diLorenzo, Kathryn Freshley and John Parker. Only mutual board directors vote for GRF directors. Ballots will […]
Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View http://www.zacks.com/stock/news/258291/glaxo-gsk-reports-in-line-q1-earnings-reiterates-view?cid=CS-ZC-FT-258291 Apr 27, 2017 - GlaxoSmithKline plc's (GSK) first quarter results came roughly in line with expectations. Glaxo reported first-quarter 2017 core earnings of 62 cents per American Depositary Share (ADS), in line with the Zacks Consensus Estimate.
Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View http://www.zacks.com/stock/news/258241/celgene-celg-tops-on-q1-earnings-sales-miss-raises-view?cid=CS-ZC-FT-258241 Apr 27, 2017 - Celgene's (CELG) first-quarter results were mixed, with the company beating on earnings but missing on sales.
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug http://www.zacks.com/stock/news/257313/abbvie-abbv-presents-positive-data-on-hcv-combination-drug?cid=CS-ZC-FT-257313 Apr 21, 2017 - AbbVie Inc. (ABBV) announced that data from two phase III studies, EXPEDITION-1 and ENDURANCE-3, evaluating its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P) for all genotypes of Hepatitis C virus (HCV)

Pages: 123

Page 1>